國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

STAT inhibitors in cancer

SpringerLink (Online service)

STAT inhibitors in cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	STAT inhibitors in canceredited by Alister C. Ward.
其他作者:	Ward, Alister C.
出版者:	Cham :Springer International Publishing :2016.
面頁冊數:	vii, 195 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	CancerMolecular aspects.
電子資源:	http://dx.doi.org/10.1007/978-3-319-42949-6
ISBN:	9783319429496$q(electronic bk.)

STAT inhibitors in cancer
STAT inhibitors in cancer[electronic resource] /edited by Alister C. Ward. - Cham :Springer International Publishing :2016. - vii, 195 p. :ill., digital ;24 cm. - Cancer drug discovery and development,2196-9906. - Cancer drug discovery and development..

STATs in Health and Disease -- STAT Proteins in Cancer -- Translating STAT Inhibitors from the Lab to the Clinic -- Historical Development of STAT3 Inhibitors and Early Results in Clinical Trials -- STAT3 Inhibitors in Cancer: A Comprehensive Update -- Targeting Upstream Janus Kinases -- Inhibitors of Upstream Inducers of STAT Activation.

This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.

ISBN: 9783319429496$q(electronic bk.)

Standard No.: 10.1007/978-3-319-42949-6doiSubjects--Topical Terms:

221221
Cancer
--Molecular aspects.

LC Class. No.: RC268.4

Dewey Class. No.: 616.99404

STAT inhibitors in cancer
LDR:01872nmm a2200325 a 4500 001 498490
003 DE-He213
005 20161008093338.0
006 m d
007 cr nn 008maaau
008 170511s2016 gw s 0 eng d
020 $a 9783319429496$q(electronic bk.)
020 $a 9783319429472$q(paper)
024 7 $a 10.1007/978-3-319-42949-6 $2 doi
035 $a 978-3-319-42949-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99404 $2 23
090 $a RC268.4 $b .S797 2016
245 0 0 $a STAT inhibitors in cancer $h [electronic resource] / $c edited by Alister C. Ward.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2016.
300 $a vii, 195 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer drug discovery and development, $x 2196-9906
505 0 $a STATs in Health and Disease -- STAT Proteins in Cancer -- Translating STAT Inhibitors from the Lab to the Clinic -- Historical Development of STAT3 Inhibitors and Early Results in Clinical Trials -- STAT3 Inhibitors in Cancer: A Comprehensive Update -- Targeting Upstream Janus Kinases -- Inhibitors of Upstream Inducers of STAT Activation.
520 $a This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.
650 0 $a Cancer $x Molecular aspects. $3 221221
650 0 $a Transcription factors. $3 202406
650 0 $a Cellular signal transduction. $3 188626
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
700 1 $a Ward, Alister C. $3 761663
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer drug discovery and development. $3 557535
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-42949-6
950 $a Medicine (Springer-11650)